| 000 | 00972nam a2200337Ia 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20220912144344.0 | ||
| 006 | a|||||r|||| 00| 0 | ||
| 007 | ta | ||
| 008 | 220909b |||||||| |||| 00| 0 eng d | ||
| 020 | _a9780123919113 (hbk) | ||
| 020 | _aSL01537900 | ||
| 024 | _a181176 | ||
| 037 | _b1037, 30/03/2012, Total Books India | ||
| 037 | _cTextual | ||
| 040 |
_aCSL _beng _cCSL |
||
| 041 | _aeng | ||
| 082 | _aLZ3:(B28), Q2 TB | ||
| 100 | _aBrody Tom | ||
| 245 | 0 | _aClinical trials : Study design, endpoints and biomarkers, drug safety, FDA and ICH guidelines | |
| 260 |
_aAmsterdam _bElsevier _c2012 |
||
| 300 | _axxxiii; 638p. | ||
| 500 | _aIndex 625-638p. | ||
| 650 | _a Clinical trials | ||
| 650 | _a Medicine | ||
| 650 | _a Pharmacognosy | ||
| 650 | _aStatistics | ||
| 700 | _aBrody Tom | ||
| 942 |
_hLZ3:(B28), Q2 TB _cTEXL _2CC |
||
| 999 |
_c5896 _d5896 |
||